All fields are required.

Close Appointment form

    Clinical Research in Ecuador – Diversity in Hispanic Community Involvement

    • Home
    • Clinical Research in Ecuador – Diversity in Hispanic Community Involvement

    Ecuador Clinical Research – Diversity in Hispanic Community Involvement

    Why is diversity important?

    FDA Action Plan

    In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including sex, age, race, and ethnicity.

    Section 907 of the FDA Safety and Innovation Act of 2012 also includes recommendations for improving the completeness and quality of analyses of data on demographic subgroups.

    In other words, most scientist, physicians and researchers are aware on how some treatments and medicines usually work differently on the demographic spectrum, some of them even harming a group while benefiting another. New research should include data from all the spectrum to ensure that particular medicine or treatment would work properly.

    Number of clinical trials per country

    According to the webpage in Latin America there are over 16 thousands studies in Latin America. Most of them conducted in Brazil, Mexico, Colombia and Argentina. Hence clinical research in Ecuador is far from being saturated.

    Figure 1. Number of Clinical Studies per Country

    Clinical Research in Ecuador 

    Ecuador Clinical Research offers Access to a diverse population

    One of the FDA’s goals is to create consciousness and make professional researchers aware about certain populations which may be more at risk for certain diseases—such as diabetes and heart disease—than others. It is important for researchers to include patients who are more likely to be treated for a condition that is common in those populations and recruit them in a trial.

    Besides, data gathered over the years have shown that there can be important differences in how people from diverse groups respond to different medical treatments. Researchers should test these products in all groups and ensure they are safe and effective in everyone who will use them.

    Information on those differences can then be included in the product labeling to help doctors and patients make treatment decisions.

    Meeting these standards could be difficult in most regions. Nevertheless, Latin America offers a vast diversity for a rapid recruitment. Most countries are multicultural and had become a great location to develop a broad-spectrum research.

    Figure 6: Population Makeup in Key Latin American Countries (%)

    Clinical Research in Ecuador

    Source: Inter ethnic ad mixture and evolution of Latin America populations, 2014

    In conclusion, these key countries in Latin America are highly diverse. For example, conducting clinical research in Ecuador will make it easier and faster to complete a recruitment process. This while your study  is collecting  more diverse data than any other region.

    [bs_button size=”md” type=”info” value=”READ THE COMPLETE REPORT HERE” href=””]

    About FOMAT Medical Research developing Clinical Research in Ecuador

    FOMAT Medical Research is pioneering Clinical Research in Ecuador, Colombia, Peru and Latin America. We are directing the Clinical Research Departments for several of the largest hospitals throughout the Americas. In Ecuador, FOMAT is a Site Management Organization (SMO) with local Contract Research Organization (CRO) capabilities.

    Diversifying Clinical Research is a top priority at FOMAT, which is why collecting data from Hispanic Sites is essential. Numerous clinical research sites in Ecuador are ready to gather diverse data for your study in record-time.

    Related Articles:

    6 Reasons to Diversify Clinical Trials

    Latin America: Reasons to run Clinical trials in the region

    Download Our Free White Paper